Rita Ambrus | Toxicology | Best Researcher Award

Posted on by sciencefather

 Rita Ambrus | Toxicology | Best Researcher Award

Full Professor at College of University of Szeged Institute of Pharmaceutical Technology and Regulatory Affairs, Hungary🎓

Prof. Dr. Rita Ambrus is a distinguished pharmaceutical scientist with a significant impact on modern drug development, particularly in the field of nanotechnology. She holds key academic leadership positions at the University of Szeged, including Vice Dean of the Faculty of Pharmacy and Vice Head of the Institute of Pharmaceutical Technology and Regulatory Affairs. Her research is well-recognized internationally, and she has contributed extensively to the scientific community through her innovative work on drug delivery systems.

Professional Profile 

Scopus

ORCID

🎓Education

Dr. Ambrus has a robust academic background, beginning with her certification as a pharmacist in 2003. She specialized as a pharmaceutical technologist in 2009 and achieved habilitation in 2015. She earned her Ph.D. in 2007, focusing on improving the solubility and dissolution rate of drugs, and later obtained a Doctor of Sciences (D.Sc.) in 2024, with a dissertation on particle size reduction processes in drug development.

💼Work Experience

Dr. Ambrus began her career at the University of Szeged as a central intern in 2006. She quickly advanced to become an assistant lecturer in 2008, followed by an assistant professor in 2014. By 2018, she was promoted to associate professor. In 2024, she was appointed as the Vice Head of the Institute of Pharmaceutical Technology and Regulatory Affairs and later became Vice Dean of the Faculty of Pharmacy. As of September 2024, she holds the position of Full Professor at the University of Szeged.

🔍Research Focus 

Dr. Ambrus’s research is centered on the development of technological processes for reducing particle size in active substances to enhance solubility, dissolution rate, permeability, and biological efficacy. She is particularly focused on alternative drug administration methods, including nasal and pulmonary delivery systems. Her work in nanotechnology has led to significant advancements in pharmaceutical sciences, with a particular emphasis on the development of innovative drug delivery systems.

🏆Awards and Honors

Dr. Ambrus has received numerous prestigious awards throughout her career, including the László Szebellédy Memorial Award in 2023 for her outstanding contributions to pharmaceutical sciences. She has also been recognized as the Young Researcher of the Year by the University of Szeged in 2019 and has been awarded various scholarships, such as the Zoltán Magyary Scholarship and the János Bolyai Research Scholarship, for her pioneering research in nanotechnology.

Conclusion

Prof. Dr. Rita Ambrus is a highly suitable candidate for the Best Researcher Award. Her extensive research contributions, numerous accolades, and leadership roles position her as a leading figure in pharmaceutical technology and drug development. With a strong academic and research background, she exemplifies the qualities sought after for this prestigious recognition. Expanding her international and industry collaborations would further enhance her already impressive portfolio.

📖Publications : 

      1. Improvement of Lidocaine Skin Permeation Using Passive and Active Enhancer Methods (2024) – International Journal of Pharmaceutics 🧴🔬
      2. Exploring Vacuum Compression Molding for Flexible-Dose Pediatric Orodispersible Films (2024) – Pharmaceuticals 👶💊
      3. Holistic Study Design for Hybrid Polymeric Nanoparticulate-Based Dry Powders as Carriers for Ciprofloxacin (2024) – Journal of Pharmaceutical Sciences 🦠💉
      4. Microencapsulation of Grape Pomace Extracts with Alginate-Based Coatings by Freeze-Drying (2024) – Gels 🍇❄️
      5. Fabrication of Ciprofloxacin-Loaded Sodium Alginate Nanobeads Coated with Thiol-Anchored Chitosan (2024) – Pharmaceutics 🧪💊
      6. Characterization of Grape Pomace Extract Microcapsules Using Carbohydrate Co-Coating (2024) – Foods 🍇🥛
      7. Preparation of a Nanosized Piroxicam Containing Orodispersible Lyophilizate (2024) – Micromachines 🌡️🧫
      8. Spray-Dried Chitosan Hydrogel Particles as a Delivery System for Benzydamine Hydrochloride (2024) – Gels 💧🦠
      9. Pulsed Laser Ablation of Polymer-Based Magnetic Nanocomposites for Oil Spill Remediation (2024) – Cleaner Materials 🌊🧲
      10. Development of a Novel Combined Dry Powder Inhaler for Pulmonary Inflammations (2024) – Pharmaceuticals 🫁

Dimple Modi | Toxicology | Best Researcher Award

Posted on by sciencefather

Dimple Modi | Toxicology | Best Researcher Award

Investigator/Principal Scientist at GlaxoSmithKline, United States 🎓

Dimple Modi is an accomplished scientific leader with over 12 years of experience in pharmaceutical research and formulation development. Specializing in dermatology/topical and parenteral applications, Modi has a proven track record in leading cross-functional teams, optimizing drug formulations, and advancing projects from conceptualization to late-stage development. With expertise in regulatory compliance, project management, and innovative drug delivery systems, Modi is known for fostering innovation and driving successful drug development initiatives.

Professional Profile 

🎓Education🧑‍🎓

Dimple Modi earned a PhD in Pharmaceutical Science from Saint Joseph’s University (formerly University of the Sciences) in Philadelphia, PA, where their research focused on enhancing the oil solubility of BCS Class II drugs and increasing drug loading in nanoemulsions. Modi also holds a Master of Science in Pharmaceutical Manufacturing Practices from Stevens Institute of Technology in Hoboken, NJ, and a Bachelor of Science in Pharmacy from L.M. College of Pharmacy in Ahmedabad, Gujarat, India.

💼Work Experience

Dimple Modi, in their role as Investigator, Drug Product Development at GlaxoSmithKline, has excelled in leading the development and optimization of long-acting injectable suspensions and parenteral solutions. Modi oversees clinical formulation strategies and project management from early to late phases, while pioneering innovative extemporaneous compounding methods. Previously, as a Senior Research Scientist at GlaxoSmithKline, Modi conducted pivotal pre-formulation studies and developed platform cream formulations using DOE methodologies. At Lupin Pharmaceuticals, Modi advanced dermatological semisolid dosage forms, managed technology transfers, and authored critical regulatory documentation. Their analytical expertise and adherence to cGMP and cGLP guidelines were honed during their tenure as an Analytical Scientist.

🔍Research Focus 

Dimple Modi’s research focuses on the development and optimization of drug formulations, particularly in dermatology and parenteral applications. Key areas include enhancing drug solubility, optimizing delivery systems, and advancing formulation strategies from lab-scale to pilot-scale manufacturing. Modi is known for innovative approaches in drug development and regulatory compliance.

🏆Awards and Honors

  • Exceptional Science Award (2018): Recognized for designing and developing a platform cream formulation that accelerated development timelines for dermatology products.
  • Multiple Bronze/Silver Awards: Received within GlaxoSmithKline for scientific accomplishments.
  • Successfully Achieved 14 ANDA Submissions and Approvals: Demonstrates significant contributions to regulatory achievements.
  • Leadership in Career Development: Actively involved in initiatives to enhance diversity and mentorship within the industry.

Conclusion

Dimple Modi’s impressive track record in pharmaceutical research, combined with leadership skills and recognized innovations, makes them a strong candidate for the “Best Researcher Award.” Their ability to drive forward complex projects, mentor future scientists, and contribute to significant advancements in drug development aligns well with the criteria for such an award. Enhancing visibility through publications and broader impact initiatives could further solidify their suitability for the award.

📖Publications : 

  1. Long acting injectables for the treatment of prostate cancer
    Modi, D., Hussain, M.S., Ainampudi, S., Prajapati, B.G.
    Journal of Drug Delivery Science and Technology, 2024, 100, 105996
  2. In situ evaluation of the impact of metformin or verapamil coadministration with vildagliptin on its regional absorption from the rabbit’s intestine
    Elmeniar, A.M., Osman, M.A., El-Gizawy, S.A., Haggag, Y.A., Tambuwala, M.M.
    Biopharmaceutics and Drug Disposition, 2024, 45(2), pp. 71–82
  3. Enhancing Oil Solubility of BCS Class II Drug Phenytoin Through Hydrophobic Ion Pairing to Enable High Drug Load in Injectable Nanoemulsion to Prevent Precipitation at Physiological pH With a Potential to Prevent Phlebitis
    Modi, D., Jonnalagadda, S., Campbell, G.A., Dalwadi, G.
    Journal of Pharmaceutical Sciences, 2023, 112(9), pp. 2427–2443
  4. Accelerate development of topical cream drug product using a common platform base formulation
    Modi, D., Sharma, H., Campbell, G.
    Pharmaceutical Development and Technology, 2020, 25(6), pp. 767–778
  5. Understanding the role of sodium lauryl sulfate on the biorelevant solubility of a combination of poorly water-soluble drugs using high throughput experimentation and mechanistic absorption modeling
    Bahr, M.N., Modi, D., Patel, S., Campbell, G., Stockdale, G.
    Journal of Pharmacy and Pharmaceutical Sciences, 2019, 22(1), pp. 221–246